
WhiteOak Capital Pharma and Healthcare Fund-Reg (G) - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
Asset Allocation
Equity: 91.74%Others: 8.26%
Market Cap
Mid Cap: 26.63%Large Cap: 17.90%Small Cap: 42.02%Equity: 5.19%
Number of stocks
60
Top 10 Holdings
95.57% of portfolio
Market Cap of Equity
Mid Cap
26.63%
Large Cap
17.90%
Small Cap
42.02%
Equity
5.19%
As of July 31, 2025
Companies Allocation of Equity
Max Healthcare Institute Ltd Ordinary Shares15.41%
Sun Pharmaceuticals Industries Ltd13.28%
Fortis Healthcare Ltd10.66%
Cipla Ltd9.56%
J.B. Chemicals & Pharmaceuticals Ltd9.17%
Laurus Labs Ltd8.88%
Divi's Laboratories Ltd8.48%
Krishna Institute of Medical Sciences Ltd7.76%
Anthem Biosciences Ltd6.51%
Apollo Hospitals Enterprise Ltd5.85%
Sector Allocation of Equity
Healthcare87.93%
Basic Materials3.23%
Financial Services0.58%
SIP Amount
₹
Monthly SIP Date
WhiteOak Capital Pharma and Healthcare Fund-Reg (G)


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.